Niva Bupa Health Insurance Company Limited (NSE:NIVABUPA)
India · Delayed Price · Currency is INR 82.62
-0.26 (-0.31%)
Aug 21, 2026, 3:29 PM IST
NSE:NIVABUPA Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Premiums & Annuity Revenue | 83,342 | 78,291 | 58,399 | 44,179 | 26,628 | 17,525 |
Total Interest & Dividend Income | 6,534 | 6,190 | 4,665 | 2,970 | 1,862 | 1,228 |
Gain (Loss) on Sale of Investments | -58.7 | -58.9 | 92.9 | 111.08 | 49.4 | 262.54 |
Other Revenue | 12.8 | 12.8 | 145.8 | 36.93 | 3,641 | 2,677 |
| 89,830 | 84,435 | 63,303 | 47,297 | 32,180 | 21,693 | |
Revenue Growth | 38.31% | 33.38% | 33.84% | 46.98% | 48.35% | 53.23% |
Policy Benefits | 78,410 | 75,611 | 55,830 | 41,280 | 14,393 | 10,886 |
Policy Acquisition & Underwriting Costs | 1,689 | - | - | - | 1,908 | 1,204 |
Depreciation & Amortization | 262.7 | 262.7 | 206.9 | 282.25 | - | - |
Selling, General & Administrative | 1,569 | 1,569 | 1,894 | 1,745 | 11,842 | 8,598 |
Provision for Bad Debts | - | - | - | - | 10.25 | 221.71 |
Other Operating Expenses | -0.5 | 203.8 | 13.2 | 28.42 | 3,634 | 2,681 |
Total Operating Expenses | 83,958 | 79,419 | 60,177 | 45,516 | 31,787 | 23,591 |
Operating Income | 5,872 | 5,015 | 3,126 | 1,781 | 393.04 | -1,899 |
Interest Expense | -370.3 | -368.9 | -365.6 | -352.02 | -267.5 | -65.23 |
Currency Exchange Gain (Loss) | - | - | - | - | -0.14 | -1.27 |
Other Non Operating Income (Expenses) | 3.4 | - | - | - | - | 0.01 |
EBT Excluding Unusual Items | 5,505 | 4,647 | 2,760 | 1,429 | 125.4 | -1,965 |
Pretax Income | 5,505 | 4,647 | 2,760 | 1,429 | 125.4 | -1,965 |
Income Tax Expense | 1,180 | 985.1 | 731.2 | 365.75 | - | - |
Net Income | 4,325 | 3,661 | 2,029 | 1,064 | 125.4 | -1,965 |
Net Income to Common | 4,325 | 3,661 | 2,029 | 1,064 | 125.4 | -1,965 |
Net Income Growth | 231.97% | 80.45% | 90.78% | 748.12% | - | - |
Shares Outstanding (Basic) | 1,844 | 1,843 | 1,753 | 1,590 | 1,463 | 1,387 |
Shares Outstanding (Diluted) | 1,859 | 1,851 | 1,782 | 1,631 | 1,503 | 1,389 |
Shares Change | 2.98% | 3.89% | 9.22% | 8.55% | 8.20% | 19.40% |
EPS (Basic) | 2.35 | 1.99 | 1.16 | 0.67 | 0.09 | -1.42 |
EPS (Diluted) | 2.33 | 1.98 | 1.14 | 0.65 | 0.08 | -1.42 |
EPS Growth | 222.10% | 73.68% | 75.39% | 712.50% | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | 9,231 | 16,440 | 8,240 | 5,547 | 3,090 |
Free Cash Flow Per Share | - | 4.99 | 9.23 | 5.05 | 3.69 | 2.23 |
Operating Margin | 6.54% | 5.94% | 4.94% | 3.77% | 1.22% | -8.75% |
Profit Margin | 4.81% | 4.34% | 3.21% | 2.25% | 0.39% | -9.06% |
Free Cash Flow Margin | - | 10.93% | 25.97% | 17.42% | 17.24% | 14.25% |
EBITDA | 6,009 | 5,148 | 3,239 | 2,015 | 485.93 | -1,810 |
EBITDA Margin | 6.69% | 6.10% | 5.12% | 4.26% | 1.51% | -8.34% |
D&A For EBITDA | 137.4 | 132.5 | 112.9 | 233.96 | 92.89 | 88.67 |
EBIT | 5,872 | 5,015 | 3,126 | 1,781 | 393.04 | -1,899 |
EBIT Margin | 6.54% | 5.94% | 4.94% | 3.77% | 1.22% | -8.75% |
Effective Tax Rate | 21.43% | 21.20% | 26.49% | 25.59% | - | - |